Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications by Correard, Florian et al.
Gold nanoparticles prepared by laser ablation in
aqueous biocompatible solutions: assessment of safety
and biological identity for nanomedicine applications.
Diane Braguer
To cite this version:
Diane Braguer. Gold nanoparticles prepared by laser ablation in aqueous biocompatible solu-
tions: assessment of safety and biological identity for nanomedicine applications.. International
Journal of Nanomedicine, 2014, 9 (1), pp.5415-5430. <10.2147/IJN.S65817>. <hal-01310706>
HAL Id: hal-01310706
https://hal-amu.archives-ouvertes.fr/hal-01310706
Submitted on 4 May 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
© 2014 Correard et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
International Journal of Nanomedicine 2014:9 5415–5430
International Journal of Nanomedicine
Gold nanoparticles prepared by laser ablation in 
aqueous biocompatible solutions: assessment of 
safety and biological identity for nanomedicine 
applications
Abstract: Due to excellent biocompatibility, chemical stability, and promising optical proper-
ties, gold nanoparticles (Au-NPs) are the focus of research and applications in nanomedicine. 
Au-NPs prepared by laser ablation in aqueous biocompatible solutions present an essentially 
novel object that is unique in avoiding any residual toxic contaminant. This paper is conceived 
as the next step in development of laser-ablated Au-NPs for future in vivo applications. The 
aim of the study was to assess the safety, uptake, and biological behavior of laser-synthesized 
Au-NPs prepared in water or polymer solutions in human cell lines. Our results showed that 
laser ablation allows the obtaining of stable and monodisperse Au-NPs in water, polyethylene 
glycol, and dextran solutions. The three types of Au-NPs were internalized in human cell lines, 
as shown by transmission electron microscopy. Biocompatibility and safety of Au-NPs were 
demonstrated by analyzing cell survival and cell morphology. Furthermore, incubation of the 
three Au-NPs in serum-containing culture medium modified their physicochemical charac-
teristics, such as the size and the charge. The composition of the protein corona adsorbed on 
Au-NPs was investigated by mass spectrometry. Regarding composition of complement C3 
proteins and apolipoproteins, Au-NPs prepared in dextran solution appeared as a promising 
drug carrier. Altogether, our results revealed the safety of laser-ablated Au-NPs in human cell 
lines and support their use for theranostic applications.
Keywords: protein corona, nanocarrier, cytotoxicity, green chemistry, neuroblastoma, 
glioblastoma
Introduction
Inorganic, organic, and hybrid nanoparticles (NPs) have been the focus of various 
research activities in nanomedicine, profiting from their tailor-made size, shape, sur-
face chemistry, and physicochemical properties.1,2 They have emerged as promising 
candidates for the vectorization of biomolecules (as nanocarriers), for bioimaging, and 
as theranostic agents3,4 – in particular, in the field of oncology.5,6 Some of them provide 
a higher therapeutic index to anticancer drugs because of a modern “vectorization” 
mechanism for targeting tumors, which does not rely on membrane permeation for 
small molecules.7 In the passive targeting mode, this mechanism is favored by the 
enhanced permeability and retention effect8 that is linked to NP physical characteristics 
and size. In the active mode, surface chemistry (including NP biomolecular corona) 
can favor targeting and biocompatibility to biological surfaces and systems. In addi-
tion, the small size, large surface area-to-volume ratio, and a multiple functionalization 
contribute to their unique biological properties. NPs can bind, adsorb, encapsulate, 
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and carry compounds such as drugs, deoxyribonucleic acid, 
ribonucleic acid, proteins, and biological probes with good 
efficiency.
Due to their chemical stability and prominent optical 
properties, gold nanoparticles (Au-NPs) have been at the 
center of attention in nanomedicine.9 These nanostructures 
are unique in supporting collective oscillations of free 
electrons (surface plasmons), which lead to a series of 
novel functionalities, including strong resonant absorption/
scattering,10 dramatic field enhancement,11,12 optical guidance 
and imaging beyond the diffraction limit,13 and ultrasensi-
tive biosensing.14,15 Their efficient optical absorption, with 
typically ~105-fold higher cross-section than absorbing dyes, 
has been employed for light-induced hyperthermia of solid 
tumors.16–18 Au-NPs can also provide the contrast for cancer 
imaging through photoacoustic19 or light scattering,20 as well 
as form mobile surface-enhanced raman scattering-based tags 
for cancer targeting and diagnosis.12 
However, conventional synthetic methods of colloidal 
metal nanostructures (NPs, nanorods, core–shells) are not 
always consistent with targeted biomedical applications. For 
instance, most Au-NP syntheses are dependent on a chemical 
reduction21 and stabilizing ligands, which generally gives rise 
to a surface contamination by residual anions, ligands, and 
reducing agents.22,23 The resulting toxicity of such nanostruc-
tures complicates their in vivo applications.23,24 
In recent syntheses, Au-NPs can be prepared by laser 
ablation in aqueous biocompatible medium, which strongly 
modifies the surface chemistry and the physical and bio-
logical properties.25 In a common experimental setup, 
an Au target immersed in aqueous media is ablated by 
intense laser radiation, yielding a natural formation of Au 
nanoclusters.26 When released to the aqueous environment, 
those nanoclusters coalesce and form a colloidal solution 
of NPs. Laser ablation in deionized water, without stabi-
lizing ligands and reagents, can lead to extremely stable 
NP solutions in a nearly monodisperse state,27,28 while the 
avoidance of such ligands and reagents promises a better 
biocompatibility. Such exceptional stability is due to an 
electrical repulsion effect resulting from a substantial nega-
tive charging of NPs produced.29 When chemical species 
are present in solution during their laser synthesis, they 
can interact with laser-formed nanoclusters, which stops 
their growth.30,31 Laser-synthesized NPs can thus exhibit 
unique surface chemistry, which makes them reactive with 
a variety of novel biocompatible materials.32 For instance, 
due to the presence of some higher oxidation states at 
high pH, they can possess O− functionalization, making 
hydrogen bonding interactions possible.29,32 Au-NPs can 
thus be noncovalently conjugated to oligosaccharides,32,33 
polymers,34 proteins,35 and oligonucleotides.36 Such direct 
conjugation (without any group ligand-specific binding) 
promotes those Au-NPs as novel classes of biocompatible 
materials for various biological applications that have been 
underdeveloped or not fully investigated. Additionally, the 
specificity of the resulting Au-NPs and their correspond-
ing molecular hard corona formed in serum should be of 
high interest for biocompatibility, targeting, biological 
transport, and delivery. Few reports describe uptake and 
cytotoxicity tests of laser-synthesized Au-NPs in vitro, but 
not in human tumor cell lines. For example, Sobhan et al37 
studied laser-synthesized Au-NPs of various sizes and their 
internalization into rat pancreatic tumor cells, while report-
ing the nontoxicity of the NPs and the size dependency in 
the cellular uptake. Taylor et al38 explored the cell uptake 
of Au-NPs in an immortalized bovine endothelial cell line. 
It was also shown that NP coating with cell-penetrating 
peptides35 or thermoresponsive polymers39 can facilitate cell 
penetration without cytotoxicity. Those scarce reports are 
thus preliminary examples of promising in vitro applications 
with laser-synthesized Au-NPs. 
However, for NP medical applications, protocols relev-
ant to their future uses should first be tested.40 In particular, 
a dose-response effect should be performed on human cell 
lines. Culture and exposure conditions such as cell den-
sity, particle concentration, medium composition, time of 
exposure, and temperature are important for cytotoxicity.41 
The biocompatibility of NPs is thus a major concern in the 
medical field. Indeed, NPs dispersed in a biological fluid 
are rapidly covered by biomolecules such as proteins, 
forming a molecular corona that influences NP proper-
ties and interaction with cells.42 This corona has never 
been investigated in laser-synthetized Au-NPs exposed to 
biological fluids.
This paper is conceived as the next step in the character-
ization and toxicological and biological assessment of the 
laser-synthesized Au-NPs in order to evaluate their potential 
for biomedical research. The presented interdisciplinary 
study addresses the interaction of newly laser-synthesized 
Au-NPs with a real biological environment appropriated to 
pharmacological applications. We used several Au-based 
nanomaterials, including ultrapure Au-NPs in deionized 
water and NPs functionalized by polymers (polyethylene 
glycol [PEG] and dextran), in order to study the response of 
some biological systems to these materials, such as biocom-
patibility, safety, and hard corona composition.
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Methods
Au-NP solutions
NPs were prepared by femtosecond (fs) laser ablation in 
liquid medium. Au target (99.99%, GoodFellow, Lille, 
France) was placed at the bottom of the glass vessel filled 
with deionized water (18.2 MΩcm) or with 1 mg/mL PEG 
(MW ~20,000, Sigma-Aldrich, St Louis, MO, USA) or 
with 1 mg/mL dextran (MW ~40,000, Sigma-Aldrich). 
A 2.3 mm diameter beam from a Yb:KGW laser (Ampli-
tude Systems, 1,025 nm, 480 fs, 95 μJ, 1 kHz) was focused 
with a 75 mm lens on the surface of a target. The target 
was constantly moved about on the focusing plane at a 
speed of 0.5 mm/s, while keeping the same thickness of 
the liquid above the target of about 1 cm. The ablation was 
performed until the solution obtained a deep red color. The 
concentration of the NPs was determined by the weight loss 
of the target after the ablation. In order to obtain the sample 
of Au-NPs in pure deionized water (Au-NPw) with nar-
row size distribution, the NPs produced by laser ablation 
underwent the laser fragmentation step as it was described 
before.30,43 Briefly, 5 mL of the previously prepared solu-
tion was placed in a glass cuvette and was irradiated for 
30 minutes by an fs laser beam of a Yb:KGW laser, focused 
in the very middle of the cuvette, using the same focusing 
lens. The energy of the laser beam was varied from 10 μJ 
to 100 μJ in order to get the NPs with different mean sizes 
and narrow size distribution. The solution was stirred 
with a magnetic stirrer during the whole fragmentation 
process. Au-NPs prepared in PEG (Au-NPp) and dextran 
(Au-NPd) solutions and polydispersed Au-NPw were 
used directly after the ablation process without a further 
fragmentation step. 
Stock solutions were sterilized by filtration (0.22 μm 
pores) before storage at room temperature. For culture and 
experiments in living cells, NPs were freshly diluted at appro-
priate concentrations in complete cell culture medium. 
Cell culture
Glioblastoma cell line (U87-MG) and neuroblastoma cell 
line (SK-N-SH) were purchased from the American Type 
Culture Collection (Manassas, VA, USA) and maintained 
in Eagle’s minimal essential medium (Invitrogen, Carls-
bad, CA, USA) and RPMI-1640 medium (Invitrogen), 
respectively, supplemented with 10% fetal bovine serum 
(FBS, Lonza, Basel, Switzerland), 2 mM L-glutamine, and 
1% penicillin streptomycin (Lonza), namely complete cell 
culture medium. All cells were routinely maintained at 37°C 
and 5% CO
2
.44
Transmission electron microscopy 
To determine the size of Au-NPs, small aliquots of NP solution 
were deposited on Formvar carbon films. After drying, cop-
per grids were directly observed with an electron microscope 
(JEOL JEM 1,400; Peabody, MA, USA). The size of Au-NPs 
was determined from the electron micrographic images with 
a MegaView III Olympus (Shinjuku, Tokyo, Japan) camera 
managed by the Soft Images System. To evaluate cellular 
uptake, cells were treated for 24 hours with Au-NPw, Au-
NPp, and Au-NPd (1 mg/L). Then, cells were washed, fixed 
with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) 
for 20 minutes, and postfixed in 1% (w/v) osmium tetroxide 
for 2 hours. Then, the cells were scraped and centrifuged. The 
pellets of cells were dehydrated in graded alcohol solution and 
embedded in Spurr low-viscosity medium. Ultrathin sections 
(50–60 nm) were counterstained with uranyl acetate and lead 
citrate before observation and analysis.
Hydrodynamic diameter and zeta 
potential analysis
Au-NPs without or after 1-hour incubation in complete cell 
culture medium were loaded into a prerinsed folded capil-
lary cell for recording the zeta potential and dynamic light 
scattering (DLS) measurements. The principle employed was 
electrophoretic light scattering according to Smoluchowski 
methodology for aqueous media at 25°C in a Zetasizer Nano ZS 
instrument (Malvern Instruments, Orsay, France). A maximum 
of 100 subruns was performed. Results are expressed as mean ± 
standard deviation from at least three independent experiments. 
Statistical analysis was done by using Student’s t-test. The value 
of P0.05 was considered statistically significant.
Cell growth experiments
Exponentially growing cells were seeded in 96-well plates for 
24 hours, and then the medium was replaced with increasing 
Au-NP concentrations (0–10 mg/L) for 72 hours. Number of 
viable cells was quantified by using the colorimetric 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT, Sigma-Aldrich) assay and/or by luminescent assay 
(CellTiter-Glo®; Promega, Madison, WI, USA) according to 
our previous works.40,45 At least three independent experi-
ments (in quadruplicate) were performed, and data were 
expressed as mean ± standard deviation.
Visualization of the microtubular network 
by immunofluorescence microscopy
U87-MG cells were seeded for 24 hours before NP or drug 
incubation on eight-well Chamber Slides (Lab-Tek®; Thermo 
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Fisher Scientific, Waltham, MA, USA). After Au-NPw 
or paclitaxel treatment for 6 hours, immunofluorescence 
staining of the microtubule network was performed using 
anti-α-tubulin primary antibody (1:400, mouse monoclonal; 
Sigma-Aldrich) and Alexa Fluor® 488-conjugated secondary 
antibody (1:20; Cell Signaling Technology, Beverly, MA, 
USA) as previously described.45 To double-label nuclei, 
cells were further stained with 4,6-diamidino-2-phenylindole 
(0.25 µg/mL; Sigma-Aldrich). Cells were observed using an 
epifluorescence microscope (Leica DM-IRBE; Wetzlar, Ger-
many), 60× objective lens, coupled to a digital camera (Cool-
SNAP FX; Princeton Instruments, Trenton, NJ, USA).
Measurement of reactive oxygen species
H
2
O
2
 production was evaluated by 2′,7′-dichlorodihydrofluor
escein diacetate (H2-DCF-DA) fluorescence (Life Technolo-
gies, Invitrogen). Cells were incubated in 96-well black plates 
for 6 hours or 24 hours with Au-NPw, Au-NPp, or Au-NPd 
at 1 mg/L and 10 mg/L. After 30 minutes of H
2
-DCF-DA 
(10 µM) incubation in white medium, the formation of DCF 
fluorescent product was measured in a Fluoroskan Ascent 
(Thermo Fisher Scientific) microplate fluorometer (510 nm 
excitation, 580 nm emission), as previously described.44
Proteomic analysis of the corona
Au-NPs (30 mg/L) were incubated for 1 hour with complete 
cell culture medium at 37°C. The NP–protein complexes 
were centrifuged at 20,000 g for 25 minutes at 4°C. Then, 
complexes were washed twice with 500 μL of phosphate 
buffered saline (PBS) at 4°C in order to maintain only the pro-
teins with the highest affinity at the NP surface (hard corona). 
Finally, all samples were incubated in a protein denaturating 
buffer (Tris 50 nM pH 6.8, bromophenol blue 0.1%, sodium 
dodecyl sulfate [SDS] 2%, β-mercaptoethanol 5%, glycerol 
10%) for 5 minutes at 95°C, and proteins were separated by 
using 8% sodium dodecyl sulfate–polyacrylamide gel (SDS-
PAGE). Protein bands were colored with Silver® protein stain 
(Thermo Fisher Scientific).
For mass spectrometry analysis, gel migration was 
stopped after a few millimeters after concentration of the 
proteins. Excised gel bands containing the mixture of proteins 
were analyzed on an LTQ Orbitrap Velos (Thermo Fisher 
Scientific) coupled online to an Ultimate 3,000 nano LC 
system (Dionex, Sunnyvale, CA, USA). Eluting peptides 
were subjected to data-dependent collision-induced dissocia-
tion fragmentation. The acquired raw data were processed 
with Proteome Discoverer (Thermo Fisher Scientific) and 
submitted to the Mascot (Matrix Science) search engine. 
All data were searched against the SWISS-PROT database 
with decoy option. The false discovery rate was calculated 
using the reversed database approach. Identified proteins 
were quantified calculating the Exponentially Modified 
Protein Abundance Index (emPAI).46 The emPAI value of an 
individual protein is applied to determine the protein content 
and is used to calculate ratios between the different samples 
for comparative analysis.
Results
Laser-assisted synthesis and characterization 
of Au-NPs
In our experiments we used methods of fs laser ablation in 
aqueous solutions, which were developed from our previous 
works.27–30,47 Briefly, an Au disc placed on the bottom of a 
glass vessel filled with aqueous solution (deionized water 
or solution of PEG or dextran) is illuminated by focused 
radiation from a Yb:KGW laser (wavelength 1,025 nm, pulse 
length 480 fs, energy per pulse 95 μJ, repetition rate 1 kHz), 
as shown in Figure 1A. The intensity of laser radiation is 
selected to ablate the Au target, and the Au nanoclusters 
are released into the liquid ambience, forming a colloidal 
NP solution. The platform with the cuvette is constantly 
moved to avoid the ablation from the same area on the target. 
The ablation process leads to a visible red coloration of the 
aqueous solution several seconds after the beginning of the 
illumination onset. NP solutions prepared by laser ablation 
in solutions of PEG and dextran look deep red (Figure 1B), 
while the solutions prepared in deionized water can addition-
ally exhibit a slight yellow tint in the reflection, associated 
with a slight broadening of NP size distribution. 
In order to produce quasi monosize dispersed distribu-
tion of Au-NPw, we additionally used methods of fs laser 
fragmentation.47 Here, Au-NPw were transferred into a glass 
vessel and illuminated by a focused laser beam (1,025 nm) 
while the deionized water solution was stirred by a magnetic 
stirrer. As we showed in our previous papers,4,7,48 in such 
fragmentation geometry the NPs are mainly ablated by white 
light supercontinuum (a broad fs length spectrum ranging 
from ultraviolet to infrared) generated over the path of the 
laser beam as a result of nonlinear self-focusing effects under 
the interaction of fs radiation with water. The fragmentation 
process led to the disappearance of yellow tints in solution 
color, associated with the narrowing of NP size. Thus, sam-
ples of Au-NPp and Au-NPd all looked deep red, as shown 
in the inset of Figure 1B, and exhibited a characteristic peak 
around 520 nm in the extinction spectra (Figure 1B), which is 
associated with the excitation of surface plasmons over NPs. 
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All samples demonstrated exceptional stability, as they did 
not show any signs of NP precipitation after several months 
of storage in glass vials. 
According to transmission electron microscopy (TEM) 
images and size distribution analysis (Figure 1C–E and 
Table 1), particles prepared from a PEG or a dextran solution 
were smaller than those produced in deionized water under 
identical conditions. The diameter of Au-NPw was similar 
when measured by TEM and DLS (20–30 nm vs 27±1 nm, 
Table 1). On the contrary, Au-NPp and Au-NPd displayed 
higher hydrodynamic diameter (HD) than diameter measured 
by TEM (45±5 nm vs 4–10 nm and 46±2 nm vs 15–25 nm, 
respectively; Table 1). Furthermore, Au-NPw were negatively 
charged, according to their zeta potential (−37.3±0.1 mV). 
Functionalizing Au-NPs with PEG and dextran significantly 
decreased the surface negative charge (−28.1±0.2 mV 
and −24.8±0.5 mV, respectively; P0.001) (Table 1). Such 
partial neutralization could come from residual cations 
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Figure 1 Synthesis of gold nanoparticles (Au-NPs) by laser ablation. (A) Schematics of laser ablation in aqueous solution. (B) Extinction spectrum of Au-NPs prepared by 
femtosecond laser ablation and further fragmentation in deionized water. The inset shows an image of a typical solution of Au-NPs. Transmission electron microscopy images and 
corresponding size distributions of laser-synthesized Au-NPs in deionized water (C), Au-NPs in solution of polyethylene glycol (D), and Au-NPs in solution of dextran (E).
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encapsulated in the polymer matrix via hydroxyl or ether 
functions. These observations are nevertheless indicative of 
a strong interaction between the polymers and NPs during 
their formation. Those interactions inducing an NP coating 
from polymers could further inhibit the seed growth, thus 
diminishing the mean particle size and narrowing the size 
distribution while ensuring the stability of NPs.36
Internalization of Au-NPw, Au-NPp,  
and Au-NPd in human cancer cells
After characterization of Au-NPs in solution, we studied the 
uptake of the three types of Au-NPs in living cells. Human 
cancer cells, such as SK-N-SH and U87-MG cells, were chosen 
according to the future use of NPs as drug delivery systems 
in cancer therapy. After incubation for 24 hours, Au-NPw, 
Au-NPp, and Au-NPd were internalized in SK-N-SH cells, 
as shown by using TEM (Figure 2A). Interestingly, Au-NPs 
entered the cells through endocytosis, as indicated by their 
presence in endocytotic vesicles (Figure 2Ba and b). Then, they 
accumulated in early and late endosomes, as well as in lyso-
somes, independently of solvent (Figure 2Bc and d). Moreover, 
Au-NPs were never visualized inside a nucleus. Internalization 
was also observed in human U87-MG cells, suggesting that NP 
uptake is not cell type specific (Figure 2C). Furthermore, the 
size of Au-NPs did not influence the cellular uptake. Indeed, 
Au-NPw entered cells whatever the size between 6±2 nm and 
19±4 nm in SK-N-SH cells (Figure S1). Altogether, these 
data demonstrated that the Au-NPs synthetized in water and 
in aqueous solutions (PEG or dextran) with size ranging from 
5 nm to 20 nm can enter human cancer cells.
Safety of Au-NPw, Au-NPp, and Au-NPd 
on human cancer cells
Because Au-NPs enter cells, it is important to verify their 
safety prior to medical use. Cytotoxicity was quantified by 
using a colorimetric MTT assay (Figure 3A). The test is 
based on the reduction of the tetrazolium salt by the mito-
chondria of living cells. The absorbance measured at 600 nm 
is proportional to the number of living cells. As a positive 
control, we used paclitaxel, which is a potent cytotoxic drug 
candidate for loading on NPs. SK-N-SH and U87-MG cell 
survival was measured after 72 hours of incubation with 
Au-NPw, Au-NPp, and Au-NPd at concentrations ranging 
from 0.1 μg/L to 10,000 μg/L. Importantly, the three Au-
NPs did not show any obvious cytotoxicity (Figure 3A). 
On the contrary, paclitaxel was cytotoxic, as shown by the 
decrease of 50% SK-N-SH and U87-MG surviving cells at 
24.3±7.9 nM and 10.6±1.4 nM, respectively (Figure 3B). 
Because NP color (red) may influence the readout, our results 
were ascertained on the two cell lines by a luminescence-
based test that quantified intracellular adenosine triphosphate 
levels, a marker of metabolically active cells (CellTiter-Glo® 
assay, 72 hours) (Figure 3C). Au-NPs induced 20% cell 
death at up to 10 mg/L concentration. 
To confirm the safety of Au-NPw, Au-NPp, and Au-NPd, 
we further investigated cell morphology and the cytoskel-
eton structure of SK-N-SH cells. Cells treated with 1 mg/L 
Au-NPs for 72 hours showed the same phenotype as control 
cells, most cells being spread out and adherent (Figure 4A). 
Control cells and cells incubated with Au-NPw (1 mg/L) 
display classical individual microtubules irradiating from the 
centrosome to the cell periphery after immunofluorescence 
staining of tubulin (Figure 4Ba and b). In contrast, paclitaxel 
at 100 nM and after 6 hours of treatment induced an unat-
tached and round cell phenotype (Figure 4Bc). In addition, 
microtubule bundles and pseudoasters were detectable in 
cells (Figure 4B), which is typical of microtubule-stabilizing 
agents.40 In parallel, H
2
O
2
 levels were measured by the 
H
2
-DCF-DA assay. Au-NPs did not induce any increase in 
reactive oxygen species production in U87-MG cells (data 
Table 1 Physicochemical characterization of Au-NPs
Au-NPw Au-NPp Au-NPd
In water
Shape (TEM) Spherical Spherical Spherical
Size (TEM) 20–30 nm 4–10 nm 15–25 nm
Size (DLS) 27±1 nm 45±5 nm 46±2 nm
PDI 0.26 0.27 0.20
Zeta potential −37.3±0.1 mV −28.1±0.2 mV −24.8±0.5 mV
In complete cell culture medium
Size (DLS) after 1 hour 57±6 nm 62±3 nm 86±9 nm
PDI 0.22 0.21 0.2
Zeta potential after 1 hour −13.9±3.2 mV −12.6±1.1 mV −14.5±0.6 mV
Abbreviations: Au-NPs, gold nanoparticles; Au-NPd, Au-NPs prepared in dextran; Au-NPp, Au-NPs prepared in polyethylene glycol; Au-NPw, Au-NPs in pure deionized 
water; DLS, dynamic light scattering; PDI, polydispersity index; TEM, transmission electron microscopy.
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not shown). Altogether, our results demonstrated the safety 
of Au-NPs when they enter cancer cells.
Biological characterization of Au-NPw, 
Au-NPp, and Au-NPd
Our previous experiments have been conducted with Au-NPs 
incubated in complete cell culture medium containing 10% 
FBS. The concentration and the nature of serum were chosen 
according to the protocols used in pharmacological studies. 
To fully characterize these promising Au-NPs in vitro, we 
determined their size, their charge, and the composition 
of the protein corona of the three types of Au-NPs in this 
biological medium.
HD and zeta potential
Sizes and charges of Au-NPs were measured after incuba-
tion in complete cell culture medium for 1 hour, followed 
by three PBS washes. Data were compared with values 
a
1 µm 1 µm 1 µm
A b c
a
500 nm 200 nm
500 nm 500 nm
500 nm 500 nm
b
c d
B
C
Figure 2 Uptake of Au-NPw, Au-NPp, and Au-NPd in human cancer cells. (A) Transmission electron microscopy images of neuroblastoma cell line cells incubated with 1 mg/L 
Au-NPw (a), Au-NPp (b), or Au-NPd (c) for 24 hours. (B) Intracellular trafficking of Au-NPw in neuroblastoma cell line cells. NPs are closed to the cell membrane (arrow) (a), 
enclosed in endocytic vesicles close to the cell membrane (arrow) (b), inside late endosome (arrow) (c), and inside endolysosome (full arrow) and lysosome (dotted arrow) 
(d). (C) Transmission electron microscopy images of glioblastoma cell line cells incubated with 1 mg/L Au-NPw for 24 hours. Au-NPw are internalized in glioblastoma cells 
(left) via endocytic vesicles (right).
Abbreviations: Au-NPs, gold nanoparticles; Au-NPd, Au-NPs prepared in dextran; Au-NPp, Au-NPs prepared in polyethylene glycol; Au-NPw, Au-NPs in pure deionized water.
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Figure 3 Safety of Au-NPs on human cancer cells. (A) MTT assay on SK-N-SH cells (left) and U87-MG cells (right) treated with Au-NPw, Au-NPp, and Au-NPd for 72 hours. 
(B) CellTiter-Glo® assay on SK-N-SH cells (left) and U87-MG cells (right) treated with Au-NPw for 72 hours. (C) MTT assay on SK-N-SH cells (left) and U87-MG cells (right) 
treated with paclitaxel as a positive control.
Abbreviations: Au-NPs, gold nanoparticles; Au-NPd, Au-NPs prepared in dextran; Au-NPp, Au-NPs prepared in polyethylene glycol; Au-NPw, Au-NPs in pure deionized 
water; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; SK-N-SH, neuroblastoma; U87-MG, glioblastoma.
obtained at the end of Au-NP synthesis (Table 1). HD of 
Au-NPs was increased by 1.3- to 2.1-fold, due to the forma-
tion of hard protein corona. Au-NPd showed the largest HD 
(86±9 nm), whereas the HD of Au-NPw and Au-NPp was 
around 60 nm (57±6 nm and 62±3 nm, respectively). This 
statistically significant difference (P0.05) suggested that 
Au-NPd bound a higher number of proteins or larger pro-
teins. The surface charge of the three Au-NPs became less 
negative after incubation in biological medium, with values 
between −12.6±1.1 mV and −14.5±0.6 mV (P0.001). 
These data indicated that proteins bound to the Au surface 
of NPs to reduce their free energy and to realize a neutral-
izing effect.
Formation of protein corona and its composition  
on Au-NPs
Protein composition of the corona of the three Au-NPs 
was analyzed by electrophoresis and mass spectrometry. 
SDS-PAGE results indicated that a protein corona was 
formed at 30 minutes of incubation and it did not distinctly 
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change after 1-hour and 24-hour incubation (Figure 5A). 
Indeed, the amount and profile of proteins look similar, as 
shown by ImageJ software analysis (Figure 5B). In order 
to anticipate their future uses as nanocarriers, we identify 
the proteins of corona formed on each Au-NP. NanoLC-
ESI-Orbitrap analysis and identification of proteins from 
the Mascot algorithm showed some differences between 
Au-NPs (Table S1). About 100 different proteins were 
adsorbed on Au-NPd, against 80 for Au-NPw and Au-NPp 
(Figure 5C). Moreover, more serum albumin (25% of 
the total of proteins for Au-NPd vs 10% for Au-NPw 
and Au-NPp) and apolipoproteins (Apos) A-I and A-II 
(particularly ApoA-I: 4.29 vs 1.3 and 2.49, respectively) 
and less complement C3 protein (0.95 vs 1.94 and 1.66, 
respectively) were adsorbed on Au-NPd (Figure 5C). 
Coagulation proteins (eg, fibrinogen, antithrombin III, 
coagulation factor VIII, hemoglobin) were found on the 
three types of Au-NPs (Table S1). 
A
a b
c d
B Control
a b c
Au-NPw 1 mg/L Paclitaxel 100 nM
Figure 4 Morphology of cancer cells after Au-NP incubation for 6 hours at 1 mg/L. (A) Phase-contrast microscopy (10×) of neuroblastoma cells control (a) or treated with 
Au-NPw (b), Au-NPp (c), or Au-NPd (d) at 1 mg/L. (B) Immunofluorescence imaging of microtubular network in glioblastoma cells control (a), incubated for 6 hours with 
Au-NPw at 1 mg/L (b) or paclitaxel at 100 nM (c). Full arrow and dotted arrow show pseudoaster and bundles, respectively.
Abbreviations: Au-NPs, gold nanoparticles; Au-NPd, Au-NPs prepared in dextran; Au-NPp, Au-NPs prepared in polyethylene glycol; Au-NPw, Au-NPs in pure deionized 
water.
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water; emPAI, Exponentially Modified Protein Abundance Index.
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Discussion
Here we have reported a detailed analysis of safety and 
biocompatibility of three spherical Au-NPs synthetized by 
fs laser ablation. This technique has the advantage of generat-
ing NPs while avoiding a contamination from NP-stabilizing 
ligands or remains from chemical reagents, which are often 
toxic to cells. The NP surface or coating is thus different 
according to the solvents and additives used during synthe-
sis: water, PEG, and dextran solutions. PEG and dextran are 
additives with some advantages in drug delivery. In fact, 
PEGylation of NPs not only provides the required biocompat-
ibility (as it is often observed in the PEGylation of proteins), 
a higher stability, and solubility in aqueous medium but also 
increases the circulation time of NPs in the blood stream for 
improving a targeted delivery without any systemic toxicity.49 
The PEG chains added to NPs to improve their biocompat-
ibility can also be functionalized, thus behaving as linkers 
to some tumor-specific ligands, toward a better targeting to 
cancer tissues and cells. With dextran as a drug carrier, the 
same advantages were reported.50 
In this work, it is the first time that biological safety 
and identity of laser-ablated Au-NPs have been determined 
according to the conditions of pharmacological applications: 
human cell lines, 37°C, 5% CO
2
, 10% FBS, cell viability 
assay for 72 hours. We have shown the safety of Au-NPw, 
Au-NPp, and Au-NPd on neuroblastoma and glioblastoma 
cells by using complementary experiments. Indeed, we failed 
to determine the concentration of Au-NPs that inhibited 50% 
of cell growth. Au-NPs at 10 mg/L induced only a 20% 
decrease in living cells after a 3-day incubation. At this high 
concentration, a decrease may reflect interference between 
Au-NPs and dye reagents rather than a cell death induction.51 
In fact, the conflicting results observed in literature on Au-NP 
toxicity may be due to the lack of normalized protocols, 
emphasizing the need to establish standards in nanotoxicol-
ogy. In addition, cell morphology, cell cytoskeleton, and 
reactive oxygen species levels were unmodified by Au-NP 
exposure, indicating that cell proliferation and motility were 
not altered. Each Au-NP was internalized in SK-N-SH and 
U87-MG cells in a polymer-independent manner. Uptake of 
Au-NPs involved endocytosis, as described in literature.52 In 
addition, SK-N-SH cells overexpress glycoprotein-P (P-gp), 
which is an efflux pump involved in resistance mechanisms 
to chemotherapy and in physiological barriers such as the 
blood–brain barrier.53 As Au-NPs enter SK-N-SH cells, they 
could be used as a drug carrier to reverse drug resistance and 
to increase efficacy of anticancer drugs, allowing them to 
reach organs protected by a barrier.54 Indeed, the nanosize 
and the specific surface biochemistry of NPs might counter-
act the P-gp functions when compared with usual smaller 
biomolecules or drugs. However, when NPs are incubated 
in biological fluid such as cell culture medium containing 
serum, proteins bind to the NP surface to make a protein 
corona. The latter has been shown to reduce internalization of 
Au-NPs, which may explain the low intracellular amount of 
Au-NPs observed.55 The corona is formed in only 30 seconds 
after incubation in a biological medium, suggesting that it 
plays a role in the toxicity profile of Au-NPs.56 In this study, 
we characterized the hard corona that remains on NPs after 
PBS washes. Formation of the corona is confirmed by the 
increase in the HD of Au-NPs. The sizes of Au-NPw, Au-
NPd, and Au-NPp remained 100 nm. 
Some water inclusion responsible for maintaining the 
protein structure, combined to the surrounding solvation 
layers, should contribute to those values. It is expected that 
an important binding mode of proteins to Au-NPs should 
come from some sulfur–Au interactions (via disulfide or 
thiol functions from proteins). The latter binding forces to 
Au-NPs are well known in nanoscience. In passive delivery, 
NPs are thus able to exploit the unique enhanced permeability 
and retention effects that enable them to leave the systemic 
circulation and to enter the extravascular space, where they 
can accumulate around and within tumor cells.57 Moreover, 
protein corona modifies the physicochemical characteristics 
of the NPs, as shown by the neutralizing effect on surface 
charge, but also changes the balance of lipophilicity and 
water solubility according to the bound proteins. The zeta 
potential remains negative, which is consistent with the low 
toxicity of Au-NPs.58 This observation confirms the need to 
measure NP charge in biological fluids before in vivo study.59 
The protein composition of the corona is relatively stable 
in time in the same medium, with few differences between 
30 minutes and 24 hours of incubation. 
Furthermore, we performed an in-depth analysis by 
mass spectrometry, which indicated some specific features 
for each Au-NP. Albumin is the most abundant protein on 
each Au-NP. Interestingly, it is known to be a hydrophobic 
protein that could facilitate the stability of a hydrophobic 
drug–NP complex via some supramolecular forces (weak 
molecular interactions) or encapsulation at the NP surface. 
Moreover, albumin is able to promote prolonged circula-
tion time in blood.60 Recently, N-albumin-bound paclitaxel 
was approved by the US Food and Drug Administration 
for clinical treatment of breast and pancreatic cancers. It is 
the first albumin NP used in cancer therapy. In addition to 
albumin binding, Au-NPs generated by fs laser ablation also 
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bound Apos. These proteins are often involved in intracel-
lular trafficking and they allow transport across biological 
barriers. ApoE or ApoA-I bound to an NP enables their 
interaction with some brain endothelial cells.61 In clinical 
assays, only a few anticancer drugs are able to cross the 
blood–brain barrier. As Au-NPs enter glioblastoma cells 
and bind to Apos, we suggest that Au-NPs could be good 
anticancer drug carrier candidates for brain tumor treatment. 
Au-NPs generated from fs laser ablation also bind immune 
proteins. It seems that Au-NPd bind less C3 complement 
protein than Au-NPw or Au-NPp. Binding complement 
factors are known to promote opsonization (internalization 
of particles or pathogens, displaying surface complement 
proteins, by phagocytic cells) but also the eventual removal 
of particles from the systemic circulation via the cells from 
the reticuloendothelial system. NPs tend to be sequestered 
in the reticuloendothelial system organs very rapidly and 
concentrate in the liver and spleen. We could suppose that 
Kupffer cells would have less affinity for Au-NPd that could 
limit hepatic accumulation of Au in vivo and subsequent 
liver toxicity.62 Moreover, more albumin and Apos were 
adsorbed at the surface of Au-NPd, suggesting that Au-NPd 
are the most promising NPs. These promising results open 
the way to investigate the safety of Au-NPs in healthy and 
tumor-bearing animals before binding Au-NPs to anticancer 
drugs. Furthermore, cell targeting could be enhanced by 
functionalizing Au-NPs with antibodies or cell-penetrating 
peptides when taking into account the roles that protein 
corona could play. In a more general concept, our results 
provide further thoughts about the evaluation of Au-NP 
toxicity, cell targeting, and delivery of NP–drug conjugates 
to fight cancer in a nanomedicinal approach.
Conclusion
Taken together, our results showed that Au-NPs prepared 
by fs laser ablation in aqueous solution were biocompatible 
and safe. Au-NPs were synthesized and functionalized using 
the performance and advantages of fs laser ablation, avoid-
ing contamination by some undesired chemicals that could 
interfere with biological studies. We demonstrated the inter-
nalization through endocytosis of Au-NPs in two malignant 
human cell lines, independently of synthesis solutions and/
or size. After exposure of NPs to serum-containing medium, 
corona proteins assembled, probably playing a major role in 
biocompatibility/toxicity and transport across physiological 
barriers of Au-NPs. This chemical, physico-optical and phar-
macological interdisciplinary approach and the convergence 
of the methods used allowed us to better understand the basic 
identity, biological behavior, and properties of functionalized 
NPs under pharmacological conditions. To conclude, a bet-
ter vectorization of anticancer drugs could take advantage 
of binding to Au-NPs, surrounded by their protein corona. 
Au-NPs could thus be effective nanocarriers for diagnosis 
agents and as drug conjugates (theranostic).
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Supplementary materials
Figure S1 Cellular uptake of gold nanoparticles of different sizes in pure deionized water. Transmission electron microscopy images of neuroblastoma cells incubated with 
1 mg/L gold nanoparticles in pure deionized water of 6 nm (A), 12 nm (B), or 19 nm (C) or polydispersed (D) for 24 hours.
A B
C D
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Table S1 List of the most abundant proteins identified on Au-NPw, Au-NPp, and Au-NPd by mass spectroscopy
Accession Mass (kDa) Name emPAI
Au-NPw Au-NPp Au-NPd
ALBU_BOVIN 71 Serum albumin 7.69 8.09 25.79
ANT3_BOVIN 53 Antithrombin-III 6.82 4.78 4.12
HBBF_BOVIN 16 Hemoglobin fetal subunit beta 5.85 7.3 16.92
HBA_BOVIN 15 Hemoglobin subunit alpha 4.02 3.1 2.35
APOE_BOVIN 36 Apolipoprotein E 3.89 2.44 1.88
TRFE_BOVIN 80 Serotransferrin 2.77 1.73 3.25
ACTB_BOVIN 42 Actin cytoplasmic 1 2.62 1.88 1.13
IBP2_BOVIN 35 Insulin-like growth factor-binding protein 2.24 2.24 2.88
THRB_BOVIN 72 Prothrombin 2.05 1.79 2.05
CO3_BOVIN 189 Complement C3 1.94 1.66 0.95
IPSP_BOVIN 45 Plasma serine protease inhibitor 1.67 2.79 3.37
GELS_BOVIN 81 Gelsolin 1.59 2.29 1.59
A1AT_BOVIN 46 Alpha-1-antiproteinase 1.44 0.99 1.28
FETUA_BOVIN 39 Alpha-2-HS-glycoprotein 1.44 1.44 2.37
RAP1B_BOVIN 21 Ras-related protein Rap-1b 1.43 1.43 0.81
APOA1_BOVIN 30 Apolipoprotein A-I 1.3 2.49 4.29
FIBB_BOVIN 54 Fibrinogen beta chain 1.29 1.04 1.43
CAP1_BOVIN 52 Adenylyl cyclase-associated protein 1 1.1 0.64 0.06
EF1A1_BOVIN 50 Elongation factor 1-alpha 1 0.77 0.88 1.14
F13A_BOVIN 23 Coagulation factor XIII A 0.51 0.51 0.73
TETN_BOVIN 23 Tetranectin 0.15 2.03 1.64
CFAH_BOVIN 145 Complement factor H 1.55 0.83
TSP1_BOVIN 133 Thrombospondin-1 0.66 1.02
KNG1_BOVIN 70 Kininogen-1 1.18 1.08
C1QB_BOVIN 27 Complement C1q subcomponent subunit B 1.28 2.66
Abbreviations: Au-NPs, gold nanoparticles; Au-NPd, Au-NPs prepared in dextran; Au-NPp, Au-NPs prepared in polyethylene glycol; Au-NPw, Au-NPs in pure deionized 
water; emPAI, Exponentially Modified Protein Abundance Index.
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